Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafael Dal-Ré

Showing results (11-20 of 79) with videos related to

Pageof 8
Sort By:
European Journal of Clinical Pharmacology|October 27, 2020
The PRECIS-2 tool seems not to be useful to discriminate the degree of pragmatism of medicine masked trials from that of open-label trialsRafael Dal-Ré
Expert Review of Clinical Pharmacology|February 20, 2020
Participants' written informed consent in low-risk pragmatic clinical trials with medicinesRafael Dal-Ré
Therapie|July 30, 2022
The winding 12-month journey of the AstraZeneca COVID-19 vaccine since its first administration to humansRafael Dal-Ré
Annals of Epidemiology|May 10, 2011
Worldwide clinical interventional studies on leading causes of death: a descriptive analysisRafael Dal-Ré
Revista Clinica Espanola|November 16, 2024
The rights and interests of participants as limits to clinical trialsRafael Dal-Ré
Trends in Cancer|February 8, 2018
Clinical Trials Transparency: Where Are We Today?Rafael Dal-Ré
Annals of the New York Academy of Sciences|August 5, 2025
Generalizability of glucagon-like peptide 1 receptor agonist clinical trial results to product labeling and the real worldRafael Dal-Ré
Accountability in Research|October 30, 2020
For how long and with what relevance do genetics articles retracted due to research misconduct remain active in the scientific literatureRafael Dal-Ré, Carmen Ayuso
Journal of Medical Genetics|July 14, 2019
Reasons for and time to retraction of genetics articles published between 1970 and 2018Rafael Dal-Ré, Carmen Ayuso
Accountability in Research|January 24, 2024
The definition of research misconduct should be stated in the abstract when reporting research on research misconductRafael Dal-Ré, Ana Marušić
Pageof 8

Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
European Journal of Clinical Pharmacology|October 27, 2020
The PRECIS-2 tool seems not to be useful to discriminate the degree of pragmatism of medicine masked trials from that of open-label trialsRafael Dal-Ré
Expert Review of Clinical Pharmacology|February 20, 2020
Participants' written informed consent in low-risk pragmatic clinical trials with medicinesRafael Dal-Ré
Therapie|July 30, 2022
The winding 12-month journey of the AstraZeneca COVID-19 vaccine since its first administration to humansRafael Dal-Ré
Annals of Epidemiology|May 10, 2011
Worldwide clinical interventional studies on leading causes of death: a descriptive analysisRafael Dal-Ré
Revista Clinica Espanola|November 16, 2024
The rights and interests of participants as limits to clinical trialsRafael Dal-Ré
Trends in Cancer|February 8, 2018
Clinical Trials Transparency: Where Are We Today?Rafael Dal-Ré
Annals of the New York Academy of Sciences|August 5, 2025
Generalizability of glucagon-like peptide 1 receptor agonist clinical trial results to product labeling and the real worldRafael Dal-Ré
Accountability in Research|October 30, 2020
For how long and with what relevance do genetics articles retracted due to research misconduct remain active in the scientific literatureRafael Dal-Ré, Carmen Ayuso
Journal of Medical Genetics|July 14, 2019
Reasons for and time to retraction of genetics articles published between 1970 and 2018Rafael Dal-Ré, Carmen Ayuso
Accountability in Research|January 24, 2024
The definition of research misconduct should be stated in the abstract when reporting research on research misconductRafael Dal-Ré, Ana Marušić
Pageof 8